ARCHIVES

FDA Codifies Rules For Expanded Access, Charging For Drugs In Clinical Trials.

This article is from The Cancer Letter archive.

Vol. 32 No. 46 | December 22, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: All 77 New NCI Positions Go to Carcinogenesis Programs; “Not Wisest Way To Use Them” – Newell

February 4, 1977

In Brief: House, Senate Authorization Measuring Waiting Floor Action; Money Bill Markups Pending

June 13, 1980

New CIS Regions Draw Support, Some Objections

July 5, 1991

Elderly and Younger Patients Have Similar Outcomes Following Radioembolization

July 26, 2013

Authorization Bill Passes Senate 82-0

June 27, 1980

American Home Products Changes Name To Wyeth.

March 1, 2002